Of note, despite multidrug therapy, PD-1+CD38+CX3CR1+ cytotoxic CD4+ T cell subset was persistently elevated in patients with difficult-to-treat RA (D2T RA), a recently recognized treatment-resistant phenotype. This evidence concerns the gene CD38 and rheumatoid arthritis.